| Comparison of intramuscular gold and sulphasalazine in the treatment of early rheumatoid arthritis. A one year prospective study. | |
| | |
MedLine Citation:
|
PMID: 8610215 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
We compared the effects of intramuscular gold and sulphasalazine on early, active rheumatoid arthritis in 128 consecutive patients. Intramuscular gold was started in the first 70 consecutive patients and sulphasalazine in the subsequent 58 patients. The patient groups were comparable with regard to clinical characteristics. In both groups clinical and laboratory parameters improved, but there was no significant difference between the two groups. The clinical improvement was most pronounced during the first three months. However, despite the clinical improvement a clear progression in radiological changes was observed in both groups, 40% of the patients taking gold and 48% of patients taking sulphasalazine discontinued the treatment because of adverse drug reactions or inefficacy during the one year follow-up. Adverse drug reactions were the main reason in both groups. These findings suggest that intramuscular gold and sulphasalazine seem to have an equal, positive effect on symptoms and clinical variables, but that radiological progression does occur in most patients none the less. |
| | |
Authors:
|
R Peltomaa; L Paimela; T Helve; M Leirisalo-Repo |
Related Documents
:
|
7192125 - Double blind cross-over trial comparing fenbufen and acetylsalicylic acid in rheumatoid... 17665425 - Seasonal birth patterns in myositis subgroups suggest an etiologic role of early enviro... 10451075 - Rheumatic manifestations in patients with thromboangiitis obliterans (buerger's disease). 1735815 - Prognostic indicators of joint destruction in systemic-onset juvenile rheumatoid arthri... 12791325 - Psychogenic seizures: clinical features and psychological analysis. 19768815 - Loss of nocturnal blood pressure fall in various extrapyramidal syndromes. |
Publication Detail:
|
Type: Clinical Trial; Comparative Study; Controlled Clinical Trial; Journal Article; Randomized Controlled Trial |
Journal Detail:
|
Title: Scandinavian journal of rheumatology Volume: 24 ISSN: 0300-9742 ISO Abbreviation: Scand. J. Rheumatol. Publication Date: 1995 |
Date Detail:
|
Created Date: 1996-05-24 Completed Date: 1996-05-24 Revised Date: 2006-11-15 |
Medline Journal Info:
|
Nlm Unique ID: 0321213 Medline TA: Scand J Rheumatol Country: NORWAY |
Other Details:
|
Languages: eng Pagination: 330-5 Citation Subset: IM |
Affiliation:
|
Department of Rheumatology, Kivelä Hospital, Helsinki, Finland. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adult Antirheumatic Agents / administration & dosage*, adverse effects Arthritis, Rheumatoid / complications, drug therapy* Female Follow-Up Studies Gold Sodium Thiomalate / administration & dosage*, adverse effects Humans Injections, Intramuscular Male Middle Aged Prospective Studies Severity of Illness Index* Sulfasalazine / administration & dosage*, adverse effects Treatment Outcome |
| Chemical | |
Reg. No./Substance:
|
0/Antirheumatic Agents; 12244-57-4/Gold Sodium Thiomalate; 599-79-1/Sulfasalazine |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Diagnosing amyloidosis.
Next Document: Comparative effects of nabumetone, naproxen, piroxicam, and diclofenac on rat gastric irritancy foll...